Learning deficits induced by chronic intraventricular infusion of quinolinic acid - Protection by MK-801 and memantine

European Journal of Pharmacology

Volumn 296, Issue 1, 1996, Pages 1-8

  Misztal, Martin ^a   Frankiewicz, Tadeusz ^a   Parsons, Chris G ^a   Danysz, Wojciech ^a  

^a MERZ PHARMACEUTICALS GMBH   (Germany)

Author keywords

i.c.v. infusion; Learning; Long term potentiation; Memantine; MK 801; Quinolinic acid

Indexed keywords

CHOLINE; DIZOCILPINE; HEMICHOLINIUM 3; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG UPTAKE; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030052030     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00682-6     Document Type: Article

References (46)

1. Bazzett, T.J., J.B. Becker, R.C. Falik and R.L. Albin, 1994, Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity, Neuroscience 60, 837.
2. Beal, M.F., 1992, Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses, Ann. Neurol. 31, 119.
3. Beal, M.F., E. Brouillet, B.C. Jenkins, R.J. Ferrante, N.W. Kowall. J.M. Miller, E. Storey, R. Srivastava, B.R. Rosen and B.T. Hyman, 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci. 13, 4181.
4. Bisaga, A., P. Krzascik, W. Palejko, E. Jankowska, W. Kostowski and W. Danysz, 1993, Effect of glutamate antagonists on NMDA- and AMPA-induced convulsant effects in mice and rats, Eur. J. Pharmacol. 242, 213.
5. Chen, H.S.V., J.W. Pellegrini, S.K. Aggarwal, S.Z. Lei, S. Warach, F.E. Jensen and S.A. Lipton, 1992. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine - therapeutic advantage against NMDA receptor-mediated neurotoxicity, J. Neurosci. 12, 4427.
6. Clements, J.D., R.A.J. Lester, G. Tong, C.E. Jahr and G.L. Westbrook, 1992, The time course of glutamate in the synaptic cleft. Science 258, 1498.
7. Collingridge, G.L. and W. Singer, 1990. Excitatory amino acid receptors and synaptic plasticity, Trends Pharmacol. Sci. 11, 290.
8. Danysz, W. and W.J. Schmidt, 1994. Glutamatergic receptors, learning and dementia: implications for the uptdate of screening methods, in: Strategies for Studying Brain Disorders: Schizophrenia, Movement and Cognitive Disorders, Vol II, eds. T. Palomo, T. Archer and R.J. Benninger (Farrand Press, Madrid) p. 313.
9. Danysz, W., M. Gossel, W. Zajaczkowski, D. Dill and G. Ouack, 1994a, Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? Case of amantadine and memantine, J. Neural Transm. [PD Sect.] 7, 155.
10. Danysz, W., M. Misztal, R.K. Filipkowski, L. Kaczmarek and J. Skangiel-Kramska, 1994b, Learning impairment induced by chronic infusion of quinolinic acid - protection by memantine. Soc. Neurosci. Abstr. 20, 1722.
11. Danysz, W., W. Zajaczkowski and C.G. Parsons. 1995, Modulation of learning processes by ionotropic glutamate receptor ligands, Behav. Pharmacol. 6, 455.
12. De la Torre, J.C., T. Fortin, G.A.S. Park, K.S. Butler, P. Kozlowski, B.A. Pappas, H. Desocarraz, J.K. Saunders and M.T. Richard, 1992, Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats, Brain Res. 582, 186.
13. De la Torre, J.C., T. Fortin, G.A.S. Park, B.A. Pappas and M.T. Richard, 1993, Brain blood flow restoration rescues chronically damaged rat CA1 neurons, Brain Res. 623, 6.
14. Globus, M.Y.T., R. Busto, W.D. Dietrich, E. Martinez, I. Valdes and M.D. Ginsberg, 1988, Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and γ-aminobutyric acid studied in intracerebral microdialysis, J. Neurochem. 51, 1455.
15. Görtelmeyer, R., M. Pantev, C.G. Parsons and G. Quack, 1993, The treatment of dementia syndrome with akatinol memantine a modulator of the glutamatergic system, in: Spektrum der Neurorehabilitation, ed. K. Von Wild (W. Zuckschwerdt Verlag, München) p. 50.
16. Greenamyre, J.T., E.F. Maragos, R.L. Albin, J.B. Penney and A.B. Young, 1988, Glutamate transmission and toxicity in Alzheimer's disease, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 12, 421.
17. Honegger, U.E., G. Quack and U.N. Wiesmann, 1993, Evidence for lysosomotropism of memantine in cultured human cells - cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and β-adrenergic transmission, Pharmacol. Toxicol. 73, 202.
18. Honey, C.R., Z. Miljkovic and J.F. MacDonald, 1985, Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid, Neurosci. Lett. 61, 135.
19. Kornhuber, J., M. Weller, K. Schoppmeyer and P. Riederer, 1994, Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties, J. Neural Transm. 43 [Suppl.], 91.
20. Lees, G.J., 1993, Contributory mechanisms in the causation of neurodegenerative disorders, Neuroscience 54, 287.
21. Leppik, I.E., K. Marienau, N.M. Graves and C.A. Rask, 1988, MK-801 for epilepsy: a pilot study, Neurology 38 (Suppl. 1), 405.
22. Lipton, S.A. and P.A. Rosenberg, 1994, Excitatory amino acids as a final common pathway for neurologic disorders, New Engl. J. Med. 330, 613.
23. Lodge, D. and K.M. Johnson, 1990, Noncompetitive excitatory amino acid receptor antagonists, Trends Pharmacol. Sci. 11, 81.
24. Meldrum, B. and J. Garthwaite, 1990, Excitatory amino acid neurotoxicity and neurodegenerative disease, Trends Pharmacol. Sci. 11, 379.
25. Misztal, M. and W. Danysz, 1995, Comparison of glutamate antagonists in continous multiple and single trial dark avoidance, Behav. Pharmacol. 6, 550.
26. Misztal, M., R.K. Filipkowski, L. Kaczmarek, J. Skangiel-Kramska and W. Danysz, 1994, Learning impairment induced by chronic infusion of quinolinic acid - a model of progressive excitotoxicity, Behav. Pharmacol. 5 [Suppl. 1], 55.
27. Mondadori, C., L. Weiskrantz, H. Buerki, F. Petschke and G.E. Fagg, 1989, NMDA receptor antagonists can enhance or impair learning performance in animals, Exp. Brain Res. 75, 449.
28. Morris, R.G.M., E. Anderson, G.S. Lynch and M. Baudry, 1986, Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5, Nature 319, 774.
29. Ni, J.W., H. Ohta, K. Matsumoto and H. Watanabe, 1994, Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats, Brain Res. 653, 231.
30. Pantev, M., R. Ritter and R. Görtelmeyer, 1993, Clinical and behavioral evaluation in long-term care patients with mild to moderate dementia under Memantine treatment, Zeitschr. Gerontopsychol. Psychiat. 6, 103.
31. Parsons, C.G., R. Gruner, J. Rozental, J. Millar and D. Lodge, 1993, Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan), Neuropharmacology 32, 1337.
32. Rogawski, M.A., 1993, Therapeutic potential of excitatory amino acid antagonists - channel blockers and 2,3-benzodiazepines, Trends Pharmacol. Sci. 14, 325.
33. Scatton, B., 1994, Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases, Life Sci. 55. 2115.
34. Spanagel, R., B. Eilbacher and R. Wilke, 1994, Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study, Eur. J. Pharmacol. 262, 21.
35. Stieg, P.E., S. Sathi, S.P. Alvarado, P.S. Jackson, J.W. Pelligrini, H.V. Chen, S.A. Lipton and F.E. Jensen, 1993. Post-stroke neuroprotection by memantine minimally affects behavior and does not block LTP, Soc. Neurosci. Abst. 19, 1502.
36. Susel, Z., T.M. Engber, S. Kuo and T.N. Chase, 1991, Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease, Neurosci. Lett. 121, 234.
37. Turski, L. and W.A. Turski, 1993, Towards an understanding of the role of glutamate in neurodegenerative disorders - energy metabolism and neuropathology, Experientia 49, 1064.
38. Vezzani, A., R. Serafini, M.A. Stasi, S. Caccia, I. Conti, R.V. Tridico and R. Samanin, 1989, Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats, J. Pharmacol. Exp. Ther. 249, 278.
39. Vezzani, A., G.L. Forloni, R. Serafini, M. Rizzi and R. Samanin, 1991, Neurodegenerative effects induced by chronic infusion of quinolinic acid in rat striatum and hippocampus, Eur. J. Neurosci. 3, 40.
40. Wenk, G.L., W. Danysz and S.L. Mobley, 1994, Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat, Brain Res. 655, 7.
41. Wenk, G.L., W. Danysz and S.L. Mobley, 1995, MK-801, memantine and amantadine show potent neuroprotective activity against NMDA toxicity in the nucleus basalis - a dose response study, Eur. J. Pharmacol. (in press).
42. Willis, C.L., C. Brazell and A.C. Foster, 1991, Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolinate-injected rat striatum, Eur. J. Pharmacol. 196, 285.
43. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat, J. Neurochem. 50, 274.
44. Yamada, K., K. Fuji, T. Nabeshima and T. Kameyama, 1990, Neurotoxicity induced by continous infusion of quinolinic acid into the lateral ventricle in rats, Neurosci. Lett. 118, 128.
45. Yamada, K., T. Nabeshima and T. Kameyama, 1991, Impairment of active avoidance response in rats with continuous infusion of quinolinic acid into the lateral ventricle, J. Pharmacobiodyn. 14, 351.
46. Zajaczkowski, W., G. Quack and W. Danysz, 1996, Infusion of ( + )-MK-801 and memantine - contrasting effects on radial maze learning in rats with entorhinal cortex lesion, Eur. J. Pharmacol. (in press).